DIAアカウントをお持ちの場合、サインインしてください。

サインイン

ユーザーIDをお忘れですか? or パスワードをお忘れですか?

Sheraton Philadelphia University City

2019年10月14日 (月) 午前 7:45 - 2019年10月17日 (木) 午後 5:00

3549 Chestnut Street, Philadelphia, PA 19104

Regulatory Affairs: The IND, NDA, and Post-Marketing

Learn about FDA regulations and expectations for the content, submission and review of INDs/NDAs, and the importance of regulatory strategy.

Continuing Education

ACPEThe Drug Information Association is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. This program is designated for up to 28.75 contact hours or 2.875 continuing education units. Type of Activity: Application; UAN: 0286-0000-19-070-L04-P

Participants must attend the entire program in order to be able to receive an ACPE statement of credit. No partial credit will be awarded.

ACPE Credit Requests MUST BE SUBMITTED by Monday, December 2, 2019
DIA is required by the Accreditation Council for Pharmacy Education (ACPE) to report pharmacy-requested CEUs through the CPE Monitor system. All ACPE-certified activity credit requests need to be submitted through DIA’s My Transcript within 45-days post activity. Pharmacists will need to provide their National Association of Boards of Pharmacy (NABP) e-Profile ID and date of birth (MMDD) to ensure the data is submitted to the ACPE and NABP properly. If you need to obtain your NABP e-Profile, please visit www.cpemonitor.net.

IACET DIA has been accredited as an Authorized Provider by the International Association for Continuing Education and Training (IACET).

As an IACET Authorized Provider, DIA offers CEUs for its programs that qualify under the ANSI/IACET Standard. DIA is authorized by IACET to offer 2.9 CEUs for this program. Participants must attend the entire program in order to be able to receive an IACET statement of credit. No partial credit will be awarded.

It is DIA policy that anyone in a position to control the content of a continuing education activity must disclose to the program audience (1) any relevant financial relationships related to the content of their presentation and/or the educational activity, and (2) discussions of unlabeled or unapproved uses of drugs or medical devices.

This educational activity may include references to the use of products for indications not approved by the FDA. Opinions expressed with regard to unapproved uses of products are solely those of the faculty and are not endorsed by DIA or any of the manufacturers of products mentioned herein. Faculty for this educational activity was asked to disclose any discussion of unlabeled or unapproved uses of drugs or medical devices.
Disclosure statements are included with each instructor's biographical sketch.

NameCredit TypeMax CreditsCEU
Regulatory Affairs: The IND, NDA, and Post-MarketiCredit TypeACPEMax Credits28.75CEU2.875
Regulatory Affairs: The IND, NDA, and Post-MarketiCredit TypeIACETMax Credits28.75CEU2.900

Statement of Credit:

If you would like to receive a statement of credit, you must attend the course, sign in at the registration desk each morning, and complete the postassessment and evaluation in the DIA Learning Center after the event. My Transcript will be available for credit request the day after the event.

Sign in to My Account to access My Transcripts and request your online credit.

To review DIA’s Disclosure and Grievance Policy, visit DIAglobal.org/CE

最新情報や機会を逃さないで

DIAのメールを購読すれば、常に最新の業界情報やイベント情報を得ることができます。